Careers in Healthcare

Are you interested in a career in our Healthcare business sector? Explore how it would feel like to work with us and what opportunities we have to offer.

As One For Patients

We are united to  help create, improve and prolong lives - as one for patients

At the Healthcare business of Merck, KGaA, Darmstadt, Germany, operating in the U.S. and Canada as EMD Serono, we discover, develop, manufacture, and market pharmaceutical and biological prescription drugs to treat cancer, multiple sclerosis, infertility, growth disorders, and certain cardiovascular and metabolic diseases. With our recent launches of Bavencio®, Mavenclad® and Tepmetko® we established our position as a Global Specialty Innovator. Our ambition now is to grow in this role, build scale and maximize our impact for patients. In our core business we build on our strong position as a leader and grow sustainably and profitably to deliver consistent results for the business and serve millions of people around the world.

With our balanced portfolio, we operate across four therapeutic areas: neurology and immunology, oncology, fertility, and cardiovascular metabolism & endocrinology. Our R&D pipeline positions us with a clear focus on strengthening our leadership positions in oncology, neurology, and immunology. We have moved to a patient-directed approach, working with patients and family carers to systematically incorporate their perspectives throughout our processes to shape the way we design and deliver healthcare.

Take a look around and explore career opportunities and growing departments in our Healthcare sector. Stay curious to find your next adventure!

Explore Opportunities

Jit Saini Quote Image Jit Saini Quote Image

"Our responsibility is to discover, develop and ultimately deliver our breakthrough therapies to patients in need all over the world, as rapidly as possible. I’m proud to be part of such a dedicated, diverse team of curious minds who always put the patient first!"

Jitinder Saini

Senior Vice President, Head of Medical Affairs EMEA

  • Global Medical Affairs

    In Global Medical Affairs, we close the gap between innovation and improved patient care. We follow the mission 'As One for Patients’ and we live it every single day while focusing on internal and external collaboration - for the benefit of patients. 

    Explore more
  • Market Access & Pricing

    Market Access & Pricing is a central pillar in realizing our organization’s ambition and goals in Healthcare. Our team works to ensure that our therapies reach patients, and the value of our treatments is recognized by payers across the world.

    Explore more
  • Global Regulatory Affairs

    Our Global Regulatory Affairs department help the healthcare organization to be an innovative science-driven company by bringing quality solutions to customers and patients. We shape the global regulatory environment, both internally and externally. 

    Explore more
  • TIP

    Our Translational Innovation Platform division is divided into two areas, namely Oncology & Immuno-Oncology and Neuroscience & Immunology. Around the world, we have teams of curious and passionate people working hard to develop innovative health solutions.

    Explore more

It's a great way to stay in touch with us and learn more about our company, career opportunities and events! Tell us more what inspires you and let us help you find your next career opportunity that aligns with your skills and interests.​

Join Now
  1. Press Releases

    Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) as a Standard ...

    Merck KGaA, Darmstadt, Germany today announced new real-world data that continue to reinforce the JAVELIN Bladder regimen as a standard of care.


  2. Press Releases

    Merck KGaA, Darmstadt, Germany, Expands Colorectal Cancer Portfolio Through ...

    Merck KGaA, Darmstadt, Germany enters licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), in development for advanced colorectal cancer.


  3. Press Releases

    Positive CHMP Opinion by EMA for Arpraziquantel to Treat Schistosomiasis in ...

    Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for arpraziquantel.




Give your career the opportunity to grow and thrive in a safe and pioneering environment focused on creating impact for customers and patients.

View All Jobs Join our Talent Zone
Chat with us Chat with us